Evidence Central | Age-related macular degeneration (AMD)

Download the app!

INSTALL

Age-related macular degeneration (AMD)

70 results

1 - 70

Macular translocation for neovascular age‐related macular degeneration
- Abstract
- Reviewer's Conclusions
Omega 3 fatty acids for preventing or slowing the progression of age‐related macular degeneration
- Abstract
- Reviewer's Conclusions
Antioxidant vitamin and mineral supplements for slowing the progression of age‐related macular degeneration
- Abstract
- Reviewer's Conclusions
Surgical implantation of steroids with antiangiogenic characteristics for treating neovascular age‐related macular degeneration
- Abstract
- Reviewer's Conclusions
Submacular surgery for choroidal neovascularisation secondary to age‐related macular degeneration
- Abstract
- Reviewer's Conclusions
Surgery for cataracts in people with age‐related macular degeneration
- Abstract
- Reviewer's Conclusions
Implantable miniature telescope (IMT) for vision loss due to end-stage age-related macular degeneration: Cochrane systematic review
- Abstract
- Summary
- Reviewer's Conclusions
Ginkgo biloba extract for age‐related macular degeneration
- Abstract
- Reviewer's Conclusions
Statins for age‐related macular degeneration
- Abstract
- Reviewer's Conclusions
Laser photocoagulation for neovascular age‐related macular degeneration
- Abstract
- Reviewer's Conclusions
Aflibercept for neovascular age‐related macular degeneration
- Abstract
- Reviewer's Conclusions
Antiangiogenic therapy with interferon alfa for neovascular age‐related macular degeneration
- Abstract
- Reviewer's Conclusions
Complement inhibitors for age‐related macular degeneration
- Abstract
- Reviewer's Conclusions
Laser treatment of drusen to prevent progression to advanced age‐related macular degeneration
- Abstract
- Reviewer's Conclusions
Antioxidant vitamin and mineral supplements for preventing age‐related macular degeneration
- Abstract
- Reviewer's Conclusions
Photobiomodulation for non‐exudative age‐related macular degeneration
- Abstract
Visual cycle modulators versus placebo or observation for the prevention and treatment of geographic atrophy due to age‐related macular degeneration
- Abstract
- Reviewer's Conclusions
Photodynamic therapy for neovascular age‐related macular degeneration
- Abstract
- Reviewer's Conclusions
Artificial intelligence for diagnosing exudative age‐related macular degeneration
- Abstract
Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration: Cochrane systematic review
- Abstract
- Summary
- Reviewer's Conclusions
Anti‐vascular endothelial growth factor for neovascular age‐related macular degeneration
- Abstract
- Reviewer's Conclusions
Radiotherapy for neovascular age‐related macular degeneration
- Abstract
- Reviewer's Conclusions
Anti‐vascular endothelial growth factor biosimilars for neovascular age‐related macular degeneration
- Abstract
- Reviewer's Conclusions
Blue‐light filtering intraocular lenses (IOLs) for protecting macular health
- Abstract
Treatment regimens for administration of anti‐vascular endothelial growth factor agents for neovascular age‐related macular degeneration
- Abstract
Blue‐light filtering spectacle lenses for visual performance, sleep, and macular health in adults
- Reviewer's Conclusions
Reading aids for adults with low vision
- Abstract
Low vision rehabilitation for better quality of life in visually impaired adults
- Abstract
1 - 70 of 70 records

Log in to Evidence Central

Contact Support

If you need further assistance, please contact Support.

unboundmedicine.com/support
support@unboundmedicine.com
610-627-9090(Monday - Friday, 9 AM - 5 PM EST.)

Password reset sent

Username sent

A Evidence Central subscription is required to

Already have an account?